ABT-299
ABT-299 is a prodrug of a platelet-activating factor (PAF) antagonist that exhibits significant inhibitory activity on PAF-induced β-platelet globulin release in vitro after in vivo administration in humans, an effect that may be partially attributed to the pyridine-N-oxide metabolite.
Product Specifications
CAS Number
161395-35-3
UNSPSC
12352005
Target
Platelet-activating Factor Receptor (PAFR)
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/abt-299.html
Smiles
CC(OC[N+]1=CC=CC([C@H]2SCC3=C(C=CN23)C(C4=CN(C5=C4C=CC(C6=CC=C(C=C6)F)=C5)C(N(C)C)=O)=O)=C1)=O.[Cl-]
Molecular Formula
C32H28ClFN4O4S
Molecular Weight
619.11
References & Citations
[1]Ex vivo inhibition of PAF-induced beta-thromboglobulin release in man by ABT-299, a potent PAF antagonist|[2]Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
368605 100 µL
ANPEP (Aminopeptidase N, APN, CD13, LAP1, P150, PEPN, GP150)
Sign In for Pricing
View Details 
MBS7196794 Inquire
Rabbit anti-Oryza sativa subsp. japonica (Rice) DI19-2 Polyclonal Antibody
Sign In for Pricing
View Details